@article{ref1,
title="Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia",
journal="Cochrane database of systematic reviews",
year="2013",
author="Adelufosi, A.O. and Abayomi, O. and Ojo, T.M.-f.",
volume="2013",
number="4",
pages="-",
abstract="This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the effects of pyridoxal 5 phosphate (pyridoxine, pyridoxal phosphate, tardoxal) for treating neuroleptic-induced tardive dyskinesia in individuals of any age group with schizophrenia and other psychotic disorders. © 2013 The Cochrane Collaboration.<p /><p>Language: en</p>",
language="en",
issn="1465-1858",
doi="10.1002/14651858.CD010501",
url="http://dx.doi.org/10.1002/14651858.CD010501"
}